Common Concerns in Patients With Fabry Disease @checkrare
Common Concerns in Patients With Fabry Disease  @checkrare
Uploaded September 2026 | Updated November 2026, 4 hours ago
Staci Kallish, DO, and Dawn Laney, MS, CGS, CCRC, examine how best to address patients’ real-life concerns about managing Fabry disease and its comorbidities. The program includes patients’ honest and candid testimonials on how their 1) symptoms are managed, 2) risk of stroke is managed, 3) risk of kidney failure is managed, and 4) physicians work as a team.
Common Concerns in Patients With Fabry DiseasePrader-Willi Syndrome: Diazoxide Choline Extended Release Improves HyperphagiaTherapies for MCT8 Deficiency and Nephrotic Syndrome Get FDA ApprovalImpact of Gazyva Approval on Patients With Idiopathic Nephrotic SyndromeOvercoming Diagnostic Odysseys With Rare Hematologic ConditionsMyasthenia Gravis Clinical Research HighlightsZ-Basivarsen Shows Functional Improvements in One-Year Data for Myotonic Dystrophy Type 1Using Plasma Proteomics to Predict Amyotrophic Lateral Sclerosis (ALS)FDA Approves Gazyva for Idiopathic Nephrotic Syndrome, Offering a New Treatment OptionGaretosmab Demonstrates Sustained Efficacy in Adults With Fibrodysplasia Ossificans ProgressivaApproval of Imaavy (Nipocalimab) and its Impact on Patients With Warm Autoimmune Hemolytic AnemiaGazyva Treatment: Steroid-Free Remission in Idiopathic Nephrotic Syndrome
CheckRare |

Common Concerns in Patients With Fabry Disease

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER